Literature DB >> 26082123

Regulated Expression Systems for Mycobacteria and Their Applications.

Dirk Schnappinger, Sabine Ehrt.   

Abstract

For bacterial model organisms like Escherichia coli and Bacillus subtilis, genetic tools to experimentally manipulate the activity of individual genes have existed for decades. But for genetically less tractable yet medically important bacteria such as Mycobacterium tuberculosis, such tools have rarely been available. More recently, several groups developed genetic switches that function efficiently in M. tuberculosis and other mycobacteria. Together these systems utilize six transcription factors, eight regulated promoters, and three regulatory principles. In this chapter we describe their design features, review their main applications, and discuss the advantages and disadvantages of regulating transcription, translation, or protein stability for controlling gene activities in bacteria. Genetic elements that enable specific and quantitative control over the activity of individual genes are irreplaceable components of the modern genetic toolbox. They facilitate not only the purification of proteins for biochemical, structural, or immunological studies but can also be applied to improve our understanding of in vivo gene functions. Until recently, only one such tool was available for use in mycobacteria, and its applicability in slowly growing mycobacteria was limited. But during the last decade at least a dozen new systems have been developed. In this chapter we review the design, components, and regulatory mechanisms of the different systems and discuss their main applications.

Entities:  

Mesh:

Year:  2014        PMID: 26082123     DOI: 10.1128/microbiolspec.MGM2-0018-2013

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  15 in total

Review 1.  Genetic Approaches to Facilitate Antibacterial Drug Development.

Authors:  Dirk Schnappinger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-13       Impact factor: 6.915

Review 2.  Fluorescent Mycobacterium tuberculosis reporters: illuminating host-pathogen interactions.

Authors:  Nathan J MacGilvary; Shumin Tan
Journal:  Pathog Dis       Date:  2018-04-01       Impact factor: 3.166

3.  Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4'-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity.

Authors:  Joanna C Evans; Dinakaran Murugesan; John M Post; Vitor Mendes; Zhe Wang; Navid Nahiyaan; Sasha L Lynch; Stephen Thompson; Simon R Green; Peter C Ray; Jeannine Hess; Christina Spry; Anthony G Coyne; Chris Abell; Helena I M Boshoff; Paul G Wyatt; Kyu Y Rhee; Tom L Blundell; Clifton E Barry; Valerie Mizrahi
Journal:  ACS Infect Dis       Date:  2021-05-03       Impact factor: 5.084

4.  Multi-Stress Induction of the Mycobacterium tuberculosis MbcTA Bactericidal Toxin-Antitoxin System.

Authors:  Kanchiyaphat Ariyachaokun; Anna D Grabowska; Claude Gutierrez; Olivier Neyrolles
Journal:  Toxins (Basel)       Date:  2020-05-16       Impact factor: 4.546

5.  Improving the stability of the TetR/Pip-OFF mycobacterial repressible promoter system.

Authors:  Francesca Boldrin; Saber Anoosheh; Agnese Serafini; Laura Cioetto Mazzabò; Giorgio Palù; Roberta Provvedi; Riccardo Manganelli
Journal:  Sci Rep       Date:  2019-04-08       Impact factor: 4.379

6.  Construction and Use of Transposon MycoTetOP 2 for Isolation of Conditional Mycobacteria Mutants.

Authors:  Sarah D Riggs-Shute; Joseph O Falkinham; Zhaomin Yang
Journal:  Front Microbiol       Date:  2020-01-21       Impact factor: 5.640

Review 7.  The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis.

Authors:  Joanna C Evans; Valerie Mizrahi
Journal:  Front Microbiol       Date:  2015-08-04       Impact factor: 5.640

8.  Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis.

Authors:  Francesca Boldrin; Giulia Degiacomi; Agnese Serafini; Gaëlle S Kolly; Marcello Ventura; Claudia Sala; Roberta Provvedi; Giorgio Palù; Stewart T Cole; Riccardo Manganelli
Journal:  Microb Biotechnol       Date:  2017-10-27       Impact factor: 5.813

9.  Tissue Distribution of Doxycycline in Animal Models of Tuberculosis.

Authors:  Martin Gengenbacher; Matthew D Zimmerman; Jansy P Sarathy; Firat Kaya; Han Wang; Marizel Mina; Claire Carter; Md Amir Hossen; Hongwei Su; Carolina Trujillo; Sabine Ehrt; Dirk Schnappinger; Véronique Dartois
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

10.  An NAD+ Phosphorylase Toxin Triggers Mycobacterium tuberculosis Cell Death.

Authors:  Diana Mendes Freire; Claude Gutierrez; Acely Garza-Garcia; Anna D Grabowska; Ambre J Sala; Kanchiyaphat Ariyachaokun; Terezie Panikova; Katherine S H Beckham; André Colom; Vivian Pogenberg; Michele Cianci; Anne Tuukkanen; Yves-Marie Boudehen; Antonio Peixoto; Laure Botella; Dmitri I Svergun; Dirk Schnappinger; Thomas R Schneider; Pierre Genevaux; Luiz Pedro Sorio de Carvalho; Matthias Wilmanns; Annabel H A Parret; Olivier Neyrolles
Journal:  Mol Cell       Date:  2019-02-18       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.